https://doi.org/10.4081/btvb.2022.31
Is transient ischemic attack a minor stroke?
Submitted: 31 March 2022
Accepted: 30 April 2022
Published: 12 May 2022
Accepted: 30 April 2022
Abstract Views: 373
PDF: 200
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
In the current literature, the utility of transient ischemic attack (TIA) diagnosis is under revision by the scientific community and experts. If initially this term was considered a valid diagnostic category, over the years the definition of TIA has been completely subverted, underlining the scientific lability of this nosological entity [...]
Easton JD, Johnston SC. Time to retire the concept of transient ischemic attack. JAMA 2022;327:813.
DOI: https://doi.org/10.1001/jama.2022.0300
A classification and outline of cerebrovascular diseases II. Stroke 1975;6:564-616.
DOI: https://doi.org/10.1161/01.STR.6.5.564
Lioutas VA, Ivan CS, Himali JJ, et al. Incidence of transient ischemic attack and association with long-term risk of stroke. JAMA 2021;325:373.
DOI: https://doi.org/10.1001/jama.2020.25071
Giles MF, Rothwell PM. Systematic review and pooled analysis of published and unpublished validations of the
ABCD and ABCD2 transient ischemic attack risk scores. Stroke 2010;41:667-73.
DOI: https://doi.org/10.1161/STROKEAHA.109.571174
Weimar C, Benemann J, Michalski D, et al. Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke. Stroke 2010;41:487-93.
DOI: https://doi.org/10.1161/STROKEAHA.109.562157
Song B, Fang H, Zhao L, et al. Validation of the ABCD 3 -I score to predict stroke risk after transient ischemic attack. Stroke 2013;44:1244-8.
DOI: https://doi.org/10.1161/STROKEAHA.113.000969
Brazzelli M, Chappell FM, Miranda H, et al. Diffusionweighted imaging and diagnosis of transient ischemic attack. Ann Neurol 2014;75:67-76.
DOI: https://doi.org/10.1002/ana.24026
Yu AYX, Coutts SB. Role of brain and vessel imaging for the evaluation of transient ischemic attack and minor stroke. Stroke 2018;49:1791-5.
DOI: https://doi.org/10.1161/STROKEAHA.118.016618
Mendelson SJ, Prabhakaran S. Diagnosis and management of transient ischemic attack and acute ischemic stroke. JAMA 2021;325:1088.
DOI: https://doi.org/10.1001/jama.2020.26867
Wang Y, Pan Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial. Circulation 2015;132:40-6.
DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.014791
Pan Y, Elm JJ, Li H, et al. Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack. JAMA Neurol 2019;76:1466.
DOI: https://doi.org/10.1001/jamaneurol.2019.2531
How to Cite
Dolcetti, E. ., Bruno, A., & Centonze, D. (2022). Is transient ischemic attack a minor stroke?. Bleeding, Thrombosis and Vascular Biology, 1(1). https://doi.org/10.4081/btvb.2022.31
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Most read articles by the same author(s)
- Federica Azzolini, Antonio Bruno, Ettore Dolcetti, Diego Centonze, Fabio Buttari, Tumor necrosis factor superfamily in multiple sclerosis: from pathology to therapeutic implications , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
Similar Articles
- Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol, The new era of anticoagulation: factor XI and XII inhibitors , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
- Sergio Coccheri, A re-appraisal of thrombogenesis in COVID-19, seen as a multiple "Complex system" , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 3 (2022)
- Rosina Albisinni, Tommaso Marrazzo, Arta Karruli, Sabrina Manduca, Giuseppe Nobile, Nicola Galdieri, Marisa De Feo, Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 3 (2022)
- Giuseppe Camporese, Paolo Prandoni, Walter Ageno, Aspirin or low-molecular weight heparin for thromboprophylaxis after a fracture? That is the question , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
- Cristina Legnani, Michela Cini, Sophie Testa, Alberto Tosetto, Claudia Dellanoce, Stefania Bellesso, Giuseppe Carli, Ilaria Nichele, Laura Lissandrini, Serena Zorzi, Emilia Antonucci, Gualtiero Palareti, Evaluation of Coaguchek®Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 3 (2022)
- Rushad Patell, Jeffrey I. Zwicker, Rohan Singh, Simon Mantha, Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. s1 (2024): 12th ICTHIC
- Marco P. Donadini, Walter Ageno, Milvexian and other drugs targeting Factor XI: a new era of anticoagulation? , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 1 (2022)
- Federica Azzolini, Antonio Bruno, Ettore Dolcetti, Diego Centonze, Fabio Buttari, Tumor necrosis factor superfamily in multiple sclerosis: from pathology to therapeutic implications , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
- Ang Li, Emily Zhou, Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. s1 (2024): 12th ICTHIC
- Bianca Clerici, Mariangela Scavone, Gian Marco Podda, Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 2 (2024)
You may also start an advanced similarity search for this article.
